GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » Notes Receivable

Prism Biolab Co (TSE:206A) Notes Receivable : 円0.0 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co Notes Receivable?

Prism Biolab Co's Notes Receivable for the quarter that ended in Sep. 2024 was 円0.0 Mil.


Prism Biolab Co Notes Receivable Historical Data

The historical data trend for Prism Biolab Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co Notes Receivable Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24
Notes Receivable
- - -

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24 Sep24
Notes Receivable - - - -

Prism Biolab Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Prism Biolab Co Notes Receivable Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Prism Biolab Co Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines